Menu

Infographic: The Role of Circadian Clocks in Muscle

Timekeepers in muscle help mediate metabolism, and may influence neurological processes such as sleep.

Sep 1, 2018
Diana Kwon

ABOVE: © ISTOCK, TIJANA87

The muscles’ intrinsic timekeepers keep the body’s metabolic pathways in sync with activity and rest cycles during the day. The muscle clock is regulated by feeding and physical activity—behaviors controlled in part by the suprachiasmatic nucleus (SCN), the body’s so-called master clock. Researchers have found that the muscle’s intrinsic rhythms could be tweaked in mice by changing the timing of feeding (Gene Dev, 14:2950–61, 2000), which is an important cue for other peripheral clocks as well. Scheduled exercise can also tune the muscle’s clocks, affecting the expression of circadian genes such as those involved in maintaining the muscles’ contractile properties (Med Sci Sports Exerc, 44:1663–70, 2012). Conversely, disrupting muscle clocks can affect sleep, suggesting that rhythms in the body’s peripheral tissues feedback on the brain, possibly through circulating hormones or other chemical messengers.

the scientist staff

Managing metabolism

One of the most clearly defined roles of a muscle’s clock is maintaining the tissue’s ability to take up glucose, a process that occurs in response to insulin levels and muscle contractions. During an animal’s waking hours, feeding—which releases insulin from the pancreas—and physical activity induce the movement of the glucose transporter GLUT4 to the cell membrane. Studies show that disrupting clock genes in the muscle impairs the transcription of GLUT4 and other key genes involved in this process.

Proteins required to metabolize sugars and lipids are also produced in a circadian manner. Researchers have found that genes that regulate the storage of these fuels reach peak expression levels when animals are preparing for rest, while those involved in breaking them down for energy production peak just before the active phase begins.

ACTIVE MUSCLE

© thom graves

MUSCLE AT REST

© thom graves

Read the full story.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.